NKNamiko Kawamura

Namiko Kawamura

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Namiko Kawamura has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Akio Inui

    Pharmacological Department of Herbal Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan

    1 shared publication
  • Atsuro Miyata

    Department of Pharmacology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan

    1 shared publication
  • Goro Katsuura

    Drug Discovery of Next-Generation GcMAF, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan

    1 shared publication
  • Nobuko Yamada-Goto

    Health Center, Keio University, Tokyo, Japan

    1 shared publication
  • Riho Nakama

    Drug Discovery of Next-Generation GcMAF, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan

    1 shared publication
  • Shuh Narumiya

    Department of Drug Discovery Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan

    1 shared publication

Latest Publications

  • Open Access

    Brain fractalkine-CX3CR1 signalling is anti-obesity system as anorexigenic and anti-inflammatory actions in diet-induced obese mice

    by Namiko Kawamura, Goro Katsuura, Nobuko Yamada-Goto, Riho Nakama, Yuki Kambe, Atsuro Miyata, Tomoyuki Furuyashiki, Shuh Narumiya, Yoshihiro Ogawa, Akio Inui

    Fractalkine is one of the CX3C chemokine family, and it is widely expressed in the brain including the hypothalamus. In the brain, fractalkine is expressed in neurons and binds to a CX3C chemokine receptor 1 (CX3CR1) in microglia. The hypothalamus regulates energy homeostasis of which dysregulation is associated with obesity. Therefore, we examined whether fractalkine-CX3CR1 signalling involved in regulating food intake and hypothalamic inflammation associated with obesity pathogenesis. In the present study, fractalkine significantly reduced food intake induced by several experimental stimuli and significantly increased brain-derived neurotrophic factor (BDNF) mRNA expression in the hypothalamus. Moreover, tyrosine receptor kinase B (TrkB) antagonist impaired fractalkine-induced anorexigenic actions. In addition, compared with wild-type mice, CX3CR1-deficient mice showed a significant increase in food intake and a significant decrease in BDNF mRNA expression in the hypothalamus. Mice fed a high-fat diet (HFD) for 16 weeks showed hypothalamic inflammation and reduced fractalkine mRNA expression in the hypothalamus. Intracerebroventricular administration of fractalkine significantly suppressed HFD-induced hypothalamic inflammation in mice. HFD intake for 4 weeks caused hypothalamic inflammation in CX3CR1-deficient mice, but not in wild-type mice. These findings suggest that fractalkine-CX3CR1 signalling induces anorexigenic actions via activation of the BDNF-TrkB pathway and suppresses HFD-induced hypothalamic inflammation in mice.